Report cover image

Global Therapeutic Vaccines Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 197 Pages
SKU # APRC20561216

Description

Summary

According to APO Research, The global Therapeutic Vaccines market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Therapeutic Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Therapeutic Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Therapeutic Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Therapeutic Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Therapeutic Vaccines include Agenus, AVAX Technologies, CIMAB S.A, Corixa, Dendreon, Northeast Biotherapeutics and Vaccinogen Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Therapeutic Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Therapeutic Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Therapeutic Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Therapeutic Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Therapeutic Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Therapeutic Vaccines sales, projected growth trends, production technology, application and end-user industry.

Therapeutic Vaccines Segment by Company

Agenus
AVAX Technologies
CIMAB S.A
Corixa
Dendreon
Northeast Biotherapeutics
Vaccinogen Inc
Therapeutic Vaccines Segment by Type

Nucleic Acid Therapeutic Vaccine
Peptide Therapeutic Vaccine
Cell Therapeutic Vaccine
Therapeutic Vaccines Segment by Application

Oncotherapy
Hepatitis B
Tuberculosis
Herpes Simplex Virus
Others
Therapeutic Vaccines Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Therapeutic Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Therapeutic Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Therapeutic Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Therapeutic Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Therapeutic Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Therapeutic Vaccines sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

197 Pages
1 Market Overview
1.1 Product Definition
1.2 Therapeutic Vaccines Market by Type
1.2.1 Global Therapeutic Vaccines Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Nucleic Acid Therapeutic Vaccine
1.2.3 Peptide Therapeutic Vaccine
1.2.4 Cell Therapeutic Vaccine
1.3 Therapeutic Vaccines Market by Application
1.3.1 Global Therapeutic Vaccines Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Oncotherapy
1.3.3 Hepatitis B
1.3.4 Tuberculosis
1.3.5 Herpes Simplex Virus
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Therapeutic Vaccines Market Dynamics
2.1 Therapeutic Vaccines Industry Trends
2.2 Therapeutic Vaccines Industry Drivers
2.3 Therapeutic Vaccines Industry Opportunities and Challenges
2.4 Therapeutic Vaccines Industry Restraints
3 Global Market Growth Prospects
3.1 Global Therapeutic Vaccines Revenue Estimates and Forecasts (2020-2031)
3.2 Global Therapeutic Vaccines Revenue by Region
3.2.1 Global Therapeutic Vaccines Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Therapeutic Vaccines Revenue by Region (2020-2025)
3.2.3 Global Therapeutic Vaccines Revenue by Region (2026-2031)
3.2.4 Global Therapeutic Vaccines Revenue Market Share by Region (2020-2031)
3.3 Global Therapeutic Vaccines Sales Estimates and Forecasts 2020-2031
3.4 Global Therapeutic Vaccines Sales by Region
3.4.1 Global Therapeutic Vaccines Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Therapeutic Vaccines Sales by Region (2020-2025)
3.4.3 Global Therapeutic Vaccines Sales by Region (2026-2031)
3.4.4 Global Therapeutic Vaccines Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Therapeutic Vaccines Revenue by Manufacturers
4.1.1 Global Therapeutic Vaccines Revenue by Manufacturers (2020-2025)
4.1.2 Global Therapeutic Vaccines Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Therapeutic Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Therapeutic Vaccines Sales by Manufacturers
4.2.1 Global Therapeutic Vaccines Sales by Manufacturers (2020-2025)
4.2.2 Global Therapeutic Vaccines Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Therapeutic Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Therapeutic Vaccines Sales Price by Manufacturers (2020-2025)
4.4 Global Therapeutic Vaccines Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Therapeutic Vaccines Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Therapeutic Vaccines Manufacturers, Product Type & Application
4.7 Global Therapeutic Vaccines Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Therapeutic Vaccines Market CR5 and HHI
4.8.2 2024 Therapeutic Vaccines Tier 1, Tier 2, and Tier 3
5 Therapeutic Vaccines Market by Type
5.1 Global Therapeutic Vaccines Revenue by Type
5.1.1 Global Therapeutic Vaccines Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Therapeutic Vaccines Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Therapeutic Vaccines Revenue Market Share by Type (2020-2031)
5.2 Global Therapeutic Vaccines Sales by Type
5.2.1 Global Therapeutic Vaccines Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Therapeutic Vaccines Sales by Type (2020-2031) & (k units)
5.2.3 Global Therapeutic Vaccines Sales Market Share by Type (2020-2031)
5.3 Global Therapeutic Vaccines Price by Type
6 Therapeutic Vaccines Market by Application
6.1 Global Therapeutic Vaccines Revenue by Application
6.1.1 Global Therapeutic Vaccines Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Therapeutic Vaccines Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Therapeutic Vaccines Revenue Market Share by Application (2020-2031)
6.2 Global Therapeutic Vaccines Sales by Application
6.2.1 Global Therapeutic Vaccines Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Therapeutic Vaccines Sales by Application (2020-2031) & (k units)
6.2.3 Global Therapeutic Vaccines Sales Market Share by Application (2020-2031)
6.3 Global Therapeutic Vaccines Price by Application
7 Company Profiles
7.1 Agenus
7.1.1 Agenus Comapny Information
7.1.2 Agenus Business Overview
7.1.3 Agenus Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Agenus Therapeutic Vaccines Product Portfolio
7.1.5 Agenus Recent Developments
7.2 AVAX Technologies
7.2.1 AVAX Technologies Comapny Information
7.2.2 AVAX Technologies Business Overview
7.2.3 AVAX Technologies Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 AVAX Technologies Therapeutic Vaccines Product Portfolio
7.2.5 AVAX Technologies Recent Developments
7.3 CIMAB S.A
7.3.1 CIMAB S.A Comapny Information
7.3.2 CIMAB S.A Business Overview
7.3.3 CIMAB S.A Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 CIMAB S.A Therapeutic Vaccines Product Portfolio
7.3.5 CIMAB S.A Recent Developments
7.4 Corixa
7.4.1 Corixa Comapny Information
7.4.2 Corixa Business Overview
7.4.3 Corixa Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Corixa Therapeutic Vaccines Product Portfolio
7.4.5 Corixa Recent Developments
7.5 Dendreon
7.5.1 Dendreon Comapny Information
7.5.2 Dendreon Business Overview
7.5.3 Dendreon Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Dendreon Therapeutic Vaccines Product Portfolio
7.5.5 Dendreon Recent Developments
7.6 Northeast Biotherapeutics
7.6.1 Northeast Biotherapeutics Comapny Information
7.6.2 Northeast Biotherapeutics Business Overview
7.6.3 Northeast Biotherapeutics Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Northeast Biotherapeutics Therapeutic Vaccines Product Portfolio
7.6.5 Northeast Biotherapeutics Recent Developments
7.7 Vaccinogen Inc
7.7.1 Vaccinogen Inc Comapny Information
7.7.2 Vaccinogen Inc Business Overview
7.7.3 Vaccinogen Inc Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Vaccinogen Inc Therapeutic Vaccines Product Portfolio
7.7.5 Vaccinogen Inc Recent Developments
8 North America
8.1 North America Therapeutic Vaccines Market Size by Type
8.1.1 North America Therapeutic Vaccines Revenue by Type (2020-2031)
8.1.2 North America Therapeutic Vaccines Sales by Type (2020-2031)
8.1.3 North America Therapeutic Vaccines Price by Type (2020-2031)
8.2 North America Therapeutic Vaccines Market Size by Application
8.2.1 North America Therapeutic Vaccines Revenue by Application (2020-2031)
8.2.2 North America Therapeutic Vaccines Sales by Application (2020-2031)
8.2.3 North America Therapeutic Vaccines Price by Application (2020-2031)
8.3 North America Therapeutic Vaccines Market Size by Country
8.3.1 North America Therapeutic Vaccines Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Therapeutic Vaccines Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Therapeutic Vaccines Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe Therapeutic Vaccines Market Size by Type
9.1.1 Europe Therapeutic Vaccines Revenue by Type (2020-2031)
9.1.2 Europe Therapeutic Vaccines Sales by Type (2020-2031)
9.1.3 Europe Therapeutic Vaccines Price by Type (2020-2031)
9.2 Europe Therapeutic Vaccines Market Size by Application
9.2.1 Europe Therapeutic Vaccines Revenue by Application (2020-2031)
9.2.2 Europe Therapeutic Vaccines Sales by Application (2020-2031)
9.2.3 Europe Therapeutic Vaccines Price by Application (2020-2031)
9.3 Europe Therapeutic Vaccines Market Size by Country
9.3.1 Europe Therapeutic Vaccines Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Therapeutic Vaccines Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Therapeutic Vaccines Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Netherlands
10 China
10.1 China Therapeutic Vaccines Market Size by Type
10.1.1 China Therapeutic Vaccines Revenue by Type (2020-2031)
10.1.2 China Therapeutic Vaccines Sales by Type (2020-2031)
10.1.3 China Therapeutic Vaccines Price by Type (2020-2031)
10.2 China Therapeutic Vaccines Market Size by Application
10.2.1 China Therapeutic Vaccines Revenue by Application (2020-2031)
10.2.2 China Therapeutic Vaccines Sales by Application (2020-2031)
10.2.3 China Therapeutic Vaccines Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Therapeutic Vaccines Market Size by Type
11.1.1 Asia Therapeutic Vaccines Revenue by Type (2020-2031)
11.1.2 Asia Therapeutic Vaccines Sales by Type (2020-2031)
11.1.3 Asia Therapeutic Vaccines Price by Type (2020-2031)
11.2 Asia Therapeutic Vaccines Market Size by Application
11.2.1 Asia Therapeutic Vaccines Revenue by Application (2020-2031)
11.2.2 Asia Therapeutic Vaccines Sales by Application (2020-2031)
11.2.3 Asia Therapeutic Vaccines Price by Application (2020-2031)
11.3 Asia Therapeutic Vaccines Market Size by Country
11.3.1 Asia Therapeutic Vaccines Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Therapeutic Vaccines Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Therapeutic Vaccines Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Therapeutic Vaccines Market Size by Type
12.1.1 SAMEA Therapeutic Vaccines Revenue by Type (2020-2031)
12.1.2 SAMEA Therapeutic Vaccines Sales by Type (2020-2031)
12.1.3 SAMEA Therapeutic Vaccines Price by Type (2020-2031)
12.2 SAMEA Therapeutic Vaccines Market Size by Application
12.2.1 SAMEA Therapeutic Vaccines Revenue by Application (2020-2031)
12.2.2 SAMEA Therapeutic Vaccines Sales by Application (2020-2031)
12.2.3 SAMEA Therapeutic Vaccines Price by Application (2020-2031)
12.3 SAMEA Therapeutic Vaccines Market Size by Country
12.3.1 SAMEA Therapeutic Vaccines Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Therapeutic Vaccines Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Therapeutic Vaccines Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Therapeutic Vaccines Value Chain Analysis
13.1.1 Therapeutic Vaccines Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Therapeutic Vaccines Production Mode & Process
13.2 Therapeutic Vaccines Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Therapeutic Vaccines Distributors
13.2.3 Therapeutic Vaccines Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.